Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The gross margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
N/A
GROSS MARGIN AVG 5Y
N/A
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
40.44%
median of 787 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Profusa, Inc. Common Stock
Market Cap
$1.84M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.84M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.93M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.65M
Gross Margin
-1128.89%
TTM Avg
-518.50%
3Y Avg
-213.30%
5Y Avg
-126.70%
Market Cap
$2.15M
Gross Margin
-628.02%
TTM Avg
-265.21%
3Y Avg
-2905.33%
5Y Avg
-2576.02%
Market Cap
$1.50M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.48M
Gross Margin
10.31%
TTM Avg
42.76%
3Y Avg
35.97%
5Y Avg
38.88%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Profusa, Inc. Common Stock (PFSA) | $1.84M | 0.00% | 0.00% | N/A | N/A |
| TransCode Therapeutics, Inc. (RNAZ)vs › | $1.84M | 0.00% | 0.00% | 0.00% | 0.00% |
| Beyond Air, Inc. (XAIR)vs › | $1.93M | 4.18% | -20.80% | -38.59% | -9.06% |
| Autonomix Medical, Inc. (AMIX)vs › | $1.93M | 0.00% | 0.00% | 0.00% | 0.00% |
| Silo Pharma, Inc. (SILO)vs › | $1.65M | -1128.89% | -518.50% | -213.30% | -126.70% |
| GeoVax Labs, Inc. (GOVX)vs › | $2.15M | -628.02% | -265.21% | -2905.33% | -2576.02% |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.50M | 0.00% | 0.00% | 0.00% | 0.00% |
| PMGC Holdings Inc. (ELAB)vs › | $1.48M | 10.31% | 42.76% | 35.97% | 38.88% |
| Curis, Inc. (CRIS)vs › | $1.47M | 99.28% | 99.31% | 98.49% | 97.34% |
| NEXGEL, Inc. (NXGL)vs › | $1.43M | 35.07% | 35.55% | 23.19% | 8.35% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
